Featured Stories

Two people stand smiling on a pathway, with a brick building and trees in the background.

Shared RNA language drives ALS research at the University of Arizona

Feb. 20, 2026

Two scientists combine complementary strengths in RNA biology and aging neuron research to advance new approaches in studying ALS, supported by the University of Arizona BIO5 Institute.

A scientist in a lab coat examines a test tube with a pink substance under a light, smiling with satisfaction.

BIO5 Fellowship moves marine research forward in the desert

Jan. 8, 2026

The postdoctoral award through the BIO5 Institute supported international collaboration, new methods, and interdisciplinary conversations that advanced a University of Arizona researcher’s ocean microbiology research far from the coast.

Group of individuals holding University of Arizona banners in front of an MRI machine.

University of Arizona celebrates new AI-powered MRI and BIO5 Brain & Body Imaging Center

Sept. 23, 2025

State-of-the-art technology and interdisciplinary expertise position the university at the forefront of imaging innovation in Arizona.

Two individuals participating in a discussion at the University of Arizona's BIO5 Institute. One is seated on a stool and speaking into a microphone, while the other listens attentively. The backdrop features the institute's logos and an abstract art piece.

Meet the scientists Behind BIO5

April 22, 2025

At an annual community event in early April, attendees heard from five accomplished University of Arizona researchers from diverse scientific disciplines during a series of intimate fireside chats. Read snapshots of these conversations.

A person smiling tenderly at a baby lying on a bed, both engaging in a joyful interaction.

A tale of two cities and a health mystery

April 16, 2025

Multiple BIO5 members lead the BEAMS study, investigating how early-life environmental exposures across the U.S.-Mexico border impact asthma risk.

Researchers launch startup to bring novel treatments to patients with asthma and COPD

April 16, 2025

BIO5 Members Julie Ledford, Josef Vagner, Stefano Guerra, and Michael D.L. Johnson co-developed an innovative inhaled asthma/COPD therapy licensed to Aspiro Therapeutics.